Key result
This review explores the mechanisms and clinical roles of current antiarrhythmic drugs and discusses recent developments in ion channel openers as potential therapies for cardiac arrhythmias.
This review summarizes the mechanisms of current anti-arrhythmic drugs and explores the potential of ion channel openers as novel therapeutics for cardiac arrhythmias.
May inform targeted antiarrhythmic use in channelopathies; leaves open clinical adoption pending prospective trials.
Voltage-gated ion channels play a fundamental role in the generation and propagation of the cardiac action potential by acting synergistically to produce an ionic current across cellular membranes.Abnormalities of heart ion channel activities that lead to loss or gain of function (channelopathies) are often associated with disruption of the coordinated propagation of electrical activity of the cardiac myocytes and can generate fatal arrhythmogenesis.Drugs that act on cardiac ion channels have long been used to restore normal rhythm and conduction in patients affected by cardiac arrhythmias and offered to basic scientists the possibility to characterize distinct ion channel classes.This review will explore the mechanisms and role of the current anti-arrhythmic drugs used in the clinic, and discuss recent development on ion channel openers as potential anti-arrhythmic drugs.
No takes yet. Share an insight, caveat, or question.
Mathew Perez Neut Vidhya Rao (2015) conducted a review in Cardiac arrhythmias. Antiarrhythmic drugs targeting voltage-gated cardiac ion channels was evaluated. This review explores the mechanisms and clinical roles of current antiarrhythmic drugs and discusses recent developments in ion channel openers as potential therapies for cardiac arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: